Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi
NCT ID: NCT04878601
Last Updated: 2023-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
470 participants
INTERVENTIONAL
2021-07-01
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi
NCT04858243
Identifying Efficient Linkage Strategies for Men
NCT05137210
Assessing Strategies for Increasing Male Involvement in Malawi's Antenatal Program
NCT02139176
Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV
NCT05074251
Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners
NCT03271307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hbART
Home-Based ART initiation and continuation for 3-months with male-specific counseling and assisted facility navigation at 4-months.
Home-Based ART
Healthcare provider will ask ART client for permission to conduct a home visit with their HIV+ partner. Providers will conduct a home visit with HIV+ partners to provide confirmatory HIV testing and ART initiation with a 30-day supply. Monthly home-based ART follow-up visits with male-specific messaging and 30-day supply distribution will take place for 3-months. At 4-months providers will provide assisted linkage to a nearby facility to join the facility-based ART program. Additional counseling will be provided.
fbART
Facility-Based ART initiation and continuation with male-specific counseling.
Facility-Based ART
Healthcare provider will ask ART client for permission to conduct a home visit with their HIV+ partner. Providers will conduct a home visit with HIV+ partners to provide confirmatory HIV testing and assisted linkage to a nearby facility for facility-based ART initiation and continuation. Male clients will receive a 30-day supply each visit and return monthly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-Based ART
Healthcare provider will ask ART client for permission to conduct a home visit with their HIV+ partner. Providers will conduct a home visit with HIV+ partners to provide confirmatory HIV testing and ART initiation with a 30-day supply. Monthly home-based ART follow-up visits with male-specific messaging and 30-day supply distribution will take place for 3-months. At 4-months providers will provide assisted linkage to a nearby facility to join the facility-based ART program. Additional counseling will be provided.
Facility-Based ART
Healthcare provider will ask ART client for permission to conduct a home visit with their HIV+ partner. Providers will conduct a home visit with HIV+ partners to provide confirmatory HIV testing and assisted linkage to a nearby facility for facility-based ART initiation and continuation. Male clients will receive a 30-day supply each visit and return monthly.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No reported interpersonal violence (IPV) as defined by World Health Organization (WHO) with the above male partner in the past 12-months
* Male partner ever tested HIV-positive
* Male partner not currently engaged in ART services, defined as:
* Tested HIV-positive ≥14 days and not on ART ≥14 days after testing HIV- positive;
* ≥14 days late for the first four-week follow up appointment; or
* Initiated ART but ≥60 days late for last ART appointment;
* Male partner living inside the facility catchment area (defined as any area that Healthcare Workers (HCWs) from the study facility routinely visit for tracing purposes)
* ≥15 years of age
* Tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold)
* Not currently engaged in ART services, defined as:
* Tested HIV-positive ≥14 days and not on ART ≥14 days after testing HIV-positive;
* ≥14 days late for the first four-week follow up appointment; or
* Initiated ART but ≥60 days late for last ART appointment;
* Has not taken ART in the past 7-days, as indicated by a point of care (POC) urine assay
* Living inside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
Exclusion Criteria
* Reported interpersonal violence (IPV) as defined by WHO with the above male partner in the past 12-months
* Male partner never tested HIV positive
* Male partner tested HIV-positive \<14 days ago
* Male partner currently engaged in ART services, defined as:
* Initiated ART \<14 days late for the first four-week follow up appointment
* Initiated ART and \<60 days late for last ART appointment
* Male partner living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
* \<15 years of age
* Never tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold)
* Tested HIV-positive \<14 days ago
* Currently engaged in ART services, defined as:
* Initiated ART
* \<14 days late for the first four-week follow up appointment
* Initiated ART and \<60 days late for last ART appointment
* Has taken ART in the past 7-days, as indicated by a point of care (POC) urine assay
* Living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes)
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Partners in Hope, Inc.
INDUSTRY
Fogarty International Center of the National Institute of Health
NIH
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kathryn L. Dovel, PhD
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Partners in Hope
Lilongwe, , Malawi
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.